Patent Application
Utility
App. No. 17/495,413
· Confirmation No. 1089
LIQUID ORAL DOSAGE FORMULATIONS OF METHYLNALTREXONE
Applicant:
Bausch Health Ireland Limited
Abandoned -- Failure to Pay Issue Fee
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2026-01-24 | ABN |
Abandonment | 1 | View | |
| 2025-10-24 | NOA |
Notice of Allowance and Fees Due (PTOL-85) | 7 | View | |
| 2025-10-01 | NOA |
Notice of Allowance and Fees Due (PTOL-85) | 11 | View | |
| 2025-10-01 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2025-10-01 | IIFW |
Issue Information including classification, examiner, name, claim, renumbering, etc. | 3 | View | |
| 2025-10-01 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2025-10-01 | SRNT |
Examiner's search strategy and results | 12 | View | |
| 2025-10-01 | SRNT |
Examiner's search strategy and results | 11 | View | |
| 2025-10-01 | 1449 |
List of References cited by applicant and considered by examiner | 5 | View | |
| 2025-08-08 | A.NE |
Response After Final Action | — | View | |
| 2025-08-08 | RCEX |
Request for Continued Examination (RCE) | 2 | View | |
| 2025-08-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-08-08 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-08-08 | XT/ |
Extension of Time | 2 | View | |
| 2025-08-08 | AMSB |
Amendment Submitted/Entered with Filing of Continued Prosecution Application (CPA)/Request for Continued Examination(RCE) | 1 | View | |
| 2025-08-08 | CLM |
Claims | 4 | View | |
| 2025-08-08 | REM |
Applicant Arguments/Remarks Made in an Amendment | 7 | View | |
| 2025-08-08 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2025-06-23 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 5 | View | |
| 2025-06-23 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-06-23 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-04-10 | CTFR |
Final Rejection | 22 | View | |
| 2025-04-10 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2025-04-10 | SRNT |
Examiner's search strategy and results | 8 | View | |
| 2025-04-10 | 1449 |
List of References cited by applicant and considered by examiner | 5 | View | |
| 2025-04-10 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2025-04-10 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2025-03-26 | N417.PYMT |
Electronic Fee Payment | 2 | View | |
| 2025-03-26 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 5 | View | |
| 2025-03-26 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-03-26 | A... |
Amendment/Request for Reconsideration-After Non-Final Rejection | 1 | View | |
| 2025-03-26 | CLM |
Claims | 6 | View | |
| 2025-03-26 | REM |
Applicant Arguments/Remarks Made in an Amendment | 7 | View | |
| 2025-01-08 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2025-01-08 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2024-12-30 | CTNF |
Non-Final Rejection | 19 | View | |
| 2024-12-30 | 892 |
List of references cited by examiner | 1 | View | |
| 2024-12-30 | SRFW |
Search information including classification, databases and other search related notes | 2 | View | |
| 2024-12-30 | SRNT |
Examiner's search strategy and results | 3 | View | |
| 2024-12-30 | 1449 |
List of References cited by applicant and considered by examiner | 3 | View | |
| 2024-12-30 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2024-12-30 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2024-12-30 | SRNT |
Examiner's search strategy and results | 35 | View | |
| 2024-12-30 | 1449 |
List of References cited by applicant and considered by examiner | 38 | View | |
| 2024-12-30 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2024-12-30 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2024-12-30 | 1449 |
List of References cited by applicant and considered by examiner | 5 | View | |
| 2024-12-30 | 1449 |
List of References cited by applicant and considered by examiner | 4 | View | |
| 2024-11-21 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-11-21 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2024-10-29 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-10-29 | ELC. |
Response to Election / Restriction Filed | 1 | View | |
| 2024-10-29 | CLM |
Claims | 6 | View | |
| 2024-10-29 | REM |
Applicant Arguments/Remarks Made in an Amendment | 3 | View | |
| 2024-10-29 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2024-10-10 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2024-10-10 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-08-29 | CTRS |
Requirement for Restriction/Election | 9 | View | |
| 2024-06-20 | FOR |
Foreign Reference | 40 | View | |
| 2024-06-20 | N417 |
Electronic Filing System Acknowledgment Receipt | 4 | View | |
| 2024-06-20 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2024-06-20 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 5 | View | |
| 2024-06-20 | FOR |
Foreign Reference | 45 | View | |
| 2024-06-20 | FOR |
Foreign Reference | 95 | View | |
| 2024-05-01 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2024-05-01 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2024-04-25 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2024-04-25 | PA.. |
Power of Attorney | 2 | View | |
| 2024-04-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2024-01-02 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 4 | View | |
| 2024-01-02 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2022-03-31 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 31 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 29 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 25 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 12 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 158 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 14 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 26 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 29 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 46 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 84 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 11 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 1 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 13 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 9 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 50 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 6 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 11 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 16 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 6 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 10 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 78 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 5 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 268 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 2 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 7 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 19 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 25 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 3 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 2 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 37 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 38 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 11 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 17 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 7 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 18 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 1 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 1 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 1 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 1 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 4 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 38 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 33 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 64 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 35 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 48 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 15 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 41 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 41 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 60 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 24 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 30 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 51 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 43 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 21 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 73 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 36 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 37 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 23 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 22 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 24 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 25 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 56 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 28 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 18 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 33 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 25 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 61 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 61 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 103 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 47 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 89 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 40 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 18 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 104 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 58 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 51 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 31 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 118 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 20 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 26 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 36 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 39 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 49 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 40 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 104 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 65 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 61 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 25 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 29 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 66 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 70 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 52 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 61 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 25 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 83 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 103 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 95 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 184 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 18 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 169 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 162 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 11 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 50 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 94 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 191 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 111 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 112 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 19 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 187 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 70 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 32 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 57 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 34 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 8 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 72 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 9 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 10 | View | |
| 2022-03-25 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 38 | View | |
| 2022-03-25 | N417 |
Electronic Filing System Acknowledgment Receipt | 8 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 50 | View | |
| 2022-03-25 | FOR |
Foreign Reference | 65 | View | |
| 2022-03-25 | REF.OTHER |
Other reference-Patent/Application/Search Documents | 16 | View | |
| 2022-03-25 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 3 | View | |
| 2021-12-22 | M327 |
Miscellaneous Communication to Applicant - No Action Count | 1 | View | |
| 2021-12-22 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2021-12-22 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2021-12-20 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 2 | View | |
| 2021-12-20 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2021-12-20 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2021-12-20 | A.PE |
Preliminary Amendment | 1 | View | |
| 2021-12-20 | CLM |
Claims | 8 | View | |
| 2021-12-20 | REM |
Applicant Arguments/Remarks Made in an Amendment | 2 | View | |
| 2021-12-09 | N570 |
Communication - Re: Power of Attorney (PTOL-308) | 1 | View | |
| 2021-12-09 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2021-12-09 | NT.INC.REPLY |
Notice of Incomplete Reply | 3 | View | |
| 2021-12-09 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2021-12-07 | ADS |
Application Data Sheet | 9 | View | |
| 2021-12-07 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2021-12-07 | CFILE |
Request for Corrected Filing Receipt | 6 | View | |
| 2021-11-18 | PA.. |
Power of Attorney | 1 | View | |
| 2021-11-18 | PA.. |
Power of Attorney | 1 | View | |
| 2021-11-18 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2021-10-20 | WCLM |
Claims Worksheet (PTO-2022) | 1 | View | |
| 2021-10-20 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2021-10-20 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2021-10-20 | APP.FILE.REC |
Filing Receipt | 4 | View | |
| 2021-10-06 | TRNA |
Transmittal of New Application | 1 | View | |
| 2021-10-06 | ADS |
Application Data Sheet | 9 | View | |
| 2021-10-06 | SPEC |
Specification | 45 | View | |
| 2021-10-06 | CLM |
Claims | 8 | View | |
| 2021-10-06 | ABST |
Abstract | 1 | View | |
| 2021-10-06 | DRW.NONBW |
Drawings-other than black and white line drawings | 6 | View | |
| 2021-10-06 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2021-10-06 | SCORE |
Placeholder sheet indicating presence of supplemental content in Supplemental Complex Repository for Examiners(SCORE) | 1 | View | |
| 2021-10-06 | DRW.SUPP |
Drawings-black and white line and/or other drawings | — | View |
Inventors
Brian R. Rohrs
Fairport, NY
Daniel J. Stein
Rochester, NY
Vijay Kumar
Webster, NY
Eric Phillips
Ontario, NY
Attorneys & Agents of Record
Classification
USPC
514/282
A61K31/485
A61K47/44
Prosecution
- Examiner
- SCHMIDT, IZABELA MARIA
- Art Unit
- 1621
- Customer No.
- 193452
- Docket No.
- 134003-5029-US03
- Confirmation No.
- 1089
Publication
- Pub. No.
- US20220096461A1
- Pub. Date
- 2022-03-31
Parent
PCT
is a Continuation of
→
PCT/EP2020/062794
Filed 2020-05-07
· Abandoned -- Failure to Pay Issue Fee
Parent
Claims priority from a provisional application
→
App. 63/010,528
Filed 2020-04-15
· Provisional Application Expired
Parent
Claims priority from a provisional application
→
App. 62/844,613
Filed 2019-05-07
· Provisional Application Expired
U.S. PATENT SECURITY AGREEMENT
Recorded 2025-11-25
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH, CANADA INC.,
BAUSCH HEALTH IRELAND LIMITED,
SOLTA MEDICAL IRELAND LIMITED
RELEASE OF SECURITY INTEREST
Recorded 2025-11-20
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-02-14
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME ON THE COVER SHEET PREVIOUSLY RECORDED AT REEL: 058152 FRAME: 0713. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT.
Recorded 2023-02-07
SECURITY AGREEMENT (FIRST LIEN)
Recorded 2022-11-04
SECURITY AGREEMENT (SECOND LIEN)
Recorded 2022-11-04
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (SECOND LIEN)
Recorded 2022-10-05
from
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH US, LLC,
MEDICIS PHARMACEUTICAL CORPORATION,
ORAPHARMA, INC.,
PRECISION DERMATOLOGY, INC.,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD.,
SANTARUS, INC.,
SOLTA MEDICAL, INC.
SECURITY AGREEMENT (FIRST LIEN)
Recorded 2022-10-04
SECURITY INTEREST
Recorded 2022-07-07
SECURITY INTEREST
Recorded 2022-07-07
from
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH IRELAND LIMITED,
BAUSCH HEALTH, CANADA INC.,
SOLTA MEDICAL IRELAND LIMITED
SECURITY INTEREST
Recorded 2022-06-13
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2021-11-18
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 17/495,413
- Filed
- 2021-10-06
- Pub. No.
- US20220096461A1
- Examiner
- SCHMIDT, IZABELA MARIA
- Art Unit
- 1621
External Links